0000899243-22-007648.txt : 20220224
0000899243-22-007648.hdr.sgml : 20220224
20220224170041
ACCESSION NUMBER: 0000899243-22-007648
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220222
FILED AS OF DATE: 20220224
DATE AS OF CHANGE: 20220224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Humphrey Jeffrey
CENTRAL INDEX KEY: 0001816944
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40499
FILM NUMBER: 22672105
MAIL ADDRESS:
STREET 1: C/O CONSTELLATION PHARMACEUTICALS, INC.
STREET 2: 215 FIRST STREET, SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662244
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455429901
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 128 SPRING STREET
STREET 2: BUILDING A, SUITE 510
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 857-285-4140
MAIL ADDRESS:
STREET 1: 128 SPRING STREET
STREET 2: BUILDING A, SUITE 510
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-22
0
0001662244
Cyteir Therapeutics, Inc.
CYT
0001816944
Humphrey Jeffrey
C/O CYTEIR THERAPEUTICS, INC.
128 SPRING ST, BUILDING A, SUITE 510
LEXINGTON
MA
02421
1
0
0
0
Stock Option (Right to Buy)
5.96
2022-02-22
4
A
0
2358
0.00
A
2032-02-22
Common Stock
2358
2358
D
The shares of common stock underlying this stock option award vest in full on February 22, 2023, subject to the Reporting Person's continued service to the board of directors of the Company through the applicable vesting date.
/s/ Andrew Gengos, Attorney-in-Fact
2022-02-24